Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase–Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell LymphomaXinhua Wang, Mingzhi Zhang, Lihong Liu et al.|JAMA Oncology|2022Cited by 61
Orelabrutinib-bruton tyrosine kinase inhibitor-based regimens in the treatment of central nervous system lymphoma: a retrospective studyJingjing Wu, Mingzhi Zhang, Wenhua Wang et al.|Investigational New Drugs|2022Cited by 44
AEG-1 is involved in hypoxia-induced autophagy and decreases chemosensitivity in T-cell lymphomaJiaqin Yan, Mingzhi Zhang, Junhui Zhang et al.|Molecular Medicine|2018Cited by 22
Outcomes of GDPT (gemcitabine, cisplatin, prednisone, thalidomide) <i>versus</i> CHOP in newly diagnosed peripheral T-cell lymphoma patientsYuanyuan Sun, Mingzhi Zhang, Ling Li et al.|Therapeutic Advances in Medical Oncology|2020Cited by 19
Radiotherapy vs sequential pegaspargase, gemcitabine, cisplatin and dexamethasone and radiotherapy in newly diagnosed early natural killer/T‐cell lymphoma: A randomized, controlled, open‐label, multicenter studyLei Zhang, Mingzhi Zhang, Yan Wang et al.|International Journal of Cancer|2020Cited by 16